Intervention

Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting1

Common conditions5

Lead sponsors shown1

Clinical trials

2 shown

PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate CancerNCT05805371 · 2024-10-09

PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate CancerNCT03873805 · 2019-08-20

ACTIVE_NOT_RECRUITING

Common conditions

Castration-Resistant Prostate Carcinoma2 Metastatic Prostate Carcinoma2 Stage IVB Prostate Cancer AJCC v82 Stage IV Prostate Cancer AJCC v81 Stage IVA Prostate Cancer AJCC v81

Leading sponsors

City of Hope Medical Center2

Trial status mix

ACTIVE_NOT_RECRUITING1

RECRUITING1

Phase mix

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.